http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e0855e1775477a611223d91e0626db67
Outgoing Links
| Predicate | Object |
|---|---|
| family-name | Ramzi M. Mohammad Mohammad M. Mohammad |
| name | Ramzi M. Mohammad Ramzi M Mohammad |
| given-name | Ramzi Ramzi M Ramzi M. |
| organization-name | 1Barbara Ann Karmanos Cancer Institute, Department of Oncology, Wayne State University School of Medicine, Detroit, Michigan. 1Department of Oncology, Wayne State University School of Medicine, Detroit, Michigan. Authors' Affiliations: 1Department of Pathology, University of Michigan Medical School; 2Interdepartmental Program in Medicinal Chemistry, 3Life Sciences Institute; 4Department of Pharmaceutical Sciences, College of Pharmacy, University of Michigan, Ann Arbor, Michigan; and 5Karmanos Cancer Institute, Wayne State University, Detroit, Michigan 2Division of Hematology and Oncology, Department of Internal Medicine, Karmanos Cancer Institute, Wayne State University, Detroit, Michigan; and Department of Oncology, Karmanos Cancer Institute, Detroit, Michigan, USA; Hamad Medical Corporation, Doha, Qatar Interim Translational Research Institute; Academic Health System; Hamad Medical Corporation; Doha Qatar Department of Oncology Karmanos Cancer Institute Wayne State University School of Medicine Detroit Michigan USA Department of Oncology Barbara Ann Karmanos Cancer Institute Wayne State University School of Medicine Detroit MI USA 1Department of Oncology, Wayne State University School of Medicine, Karmanos Cancer Institute, Detroit, Michigan. Department of Oncology, Wayne State University School of Medicine, Karmanos Cancer Institute, Detroit, Michigan Department of Oncology, Wayne State University School of Medicine, Detroit, MI, USA; Molecular Therapeutics Program, Barbara Ann Karmanos Cancer Institute, Wayne State University School of Medicine, Detroit, MI, USA Translational Research Institute, Academic Health System, Hamad Medical Corporation, Doha, Qatar; Department of Oncology Karmanos Cancer Institute Wayne State University 4100 John R, HWCRC, Room 732 48201 Detroit MI USA; Hamad Medical Corporation Doha Qatar Asfar S. Azmi and Ramzi M. Mohammad, Wayne State University School of Medicine, Detroit, MI Authors' Affiliations: 1Department of Pathology and 2Division of Hematology and Oncology, Department of Internal Medicine, Karmanos Cancer Institute, Wayne State University School of Medicine, Detroit, Michigan Department of Oncology, Karmanos Cancer Institute, Wayne State University, 4100 John R, HWCRC 732, Detroit MI 48201, USA; Division of Research, Hamad Medical Corporation, Doha, Qatar Departments of Oncology, Karmanos Cancer Institute, Wayne State University School of Medicine, Detroit, Michigan 2Division of Hematology and Oncology, Barbara Ann Karmanos Cancer Institute, Wayne State University School of Medicine, Detroit, Michigan; and From The Molecular Therapeutics Program, the Sloan-Kettering Institute; the Department of Medicine, the Division of Hematology-Oncology and the Division of Solid Tumor Oncology, Memorial Sloan-Kettering Cancer Center; New York, NY; and the Division of Hematology and Oncology, the Department of Internal Medicine, Wayne State University School of Medicine, Karmanos Cancer Institute, Detroit, MI. Translational Research Institute, Hamad Medical Corporation, Doha, Qatar Department of Pathology & Oncology, Karmanos Cancer Institute, Wayne State University, Detroit MI 48201, USA 1Division of Hematology and Oncology, Department of Internal Medicine, Karmanos Cancer Institute, Wayne State University School of Medicine, Detroit, Michigan and Genomic Core Facility, Translational Research Institute, Academic Health System; Hamad Medical Corporation; Doha 3050 Qatar Department of Oncology, Wayne State University School of Medicine, Detroit, MI 48201, USA Department of Oncology, Barbara Ann Karmanos Cancer Institute, Wayne State University School of Medicine, Detroit, MI, USA Department of Oncology, Wayne State University School of Medicine, 4100 John R, HWCRC 732, Detroit, MI 48201, USA; iTRI, Hamad Medical Corporation, Doha, Qatar 4100 John R, HWCRC 732, Detroit MI 48201, USA. Department of Pathology and Division of Hematology and Oncology, Barbara Ann Karmanos Cancer Institute, School of Medicine, Wayne State University, Detroit, Michigan 48201 1Karmanos Cancer Institute, Department of Oncology, School of Medicine, Wayne State University, Detroit, Michigan. 1Department of Internal Medicine, Division of Hematology and Oncology, Karmanos Cancer Institute, Wayne State University School of Medicine, Detroit, Michigan and 1Department of Pathology and; 2Department of Internal Medicine, Division of Hematology/Oncology, Wayne State University School of Medicine, Karmanos Cancer Institute, Detroit, Michigan; Translational Research Institute, Academic Health System, Hamad Medical Corporation, PO Box 3050, Doha, Qatar Authors' Affiliations: 1Veterans Affairs Medical Center, 2Karmanos Cancer Institute, 3Graduate Program in Cancer Biology, School of Medicine, and Departments of 4Internal Medicine and 5Pathology, Wayne State University, Detroit, Michigan; Authors' Affiliations: 1Veterans Affairs Medical Center, 2Karmanos Cancer Institute, 3Graduate Program in Cancer Biology, School of Medicine, and Departments of 4Internal Medicine and 5Pathology, Wayne State University, Detroit, Michigan Department of Oncology, Karmanos Cancer Institute, Wayne State University School of Medicine, Detroit, MI, USA Division of Hematology and Oncology, Karmanos Cancer Institute, Wayne State University School of Medicine, Detroit, MI 48201, USA. [email protected] |
Incoming Links
Showing number of triples: 1 to 185 of 185.